Medical Condition News

RSS

EDAP announces placement of first Sonolith i-sys electroconductive lithotripter in South Africa

EDAP TMS SA, the global leader in therapeutic ultrasound, reported today placement of the first Sonolith i-sys electroconductive lithotripter in South Africa.

21 Jan 2011

Scientist receives RO1 research grant to improve blood, marrow transplantation in myeloma patients

Thea Friedman, M.D., associate scientist and director of oncology basic research at the John Theurer Cancer Center at Hackensack University Medical Center was recently awarded a National Cancer Institutes of Health-National Cancer Institute RO1 research grant to improve allogeneic blood and marrow transplantation for multiple myeloma patients.

21 Jan 2011

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease (PAD) who undergo an angioplasty and stent procedure in the superficial femoral artery.

21 Jan 2011

Study evaluates Masimo SpHb's accuracy in monitoring low hemoglobin levels

Masimo announced today that a new study demonstrating the clinical accuracy and value of its noninvasive and continuous hemoglobin monitoring technology breakthrough was presented this week at the Society of Critical Care Medicine Annual Critical Care Congress in San Diego.

21 Jan 2011

Researchers examine brain's role in breathing

Much of our knowledge of the brain's role in regulating breathing comes from research with mice and rats. A chemical receptor within the brain stem communicates with the central nervous system to generate the basic pattern of breathing. The next step is applying that information to human tissue to identify these critical components in the human brain and their medical implications.

21 Jan 2011

MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium

The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE, a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of outpatients with bipolar disorder.

21 Jan 2011

Cell binding mechanism can lead to new treatments for skin diseases, lethal heart defects

A University of Manchester scientist has revealed the mechanism that binds skin cells tightly together, which he believes will lead to new treatments for painful and debilitating skin diseases and also lethal heart defects.

From The University of Manchester 21 Jan 2011

EHSI's NASA bioreactor will help reduce pain and trauma caused by harvesting of adult stem cells

Emerging Healthcare Solutions, Inc. expects that the company's NASA-developed bioreactor will help reduce patients' pain and trauma caused by the harvesting of adult stem cells for therapeutic and research purposes, said EHSI President and CEO Cindy Morrissey.

21 Jan 2011

INF2 gene mutation is a major cause for focal segmental glomerulosclerosis

Mutations in a gene called INF2 are by far the most common cause of a dominantly inherited condition that leads to kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results may help with screening, prevention, and therapy.

21 Jan 2011

Routine mammograms can show arterial calcium deposits in women with ESRD, CKD

Routine mammograms performed for breast cancer screening could serve another purpose as well: detecting calcifications in the blood vessels of patients with advanced kidney disease, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

21 Jan 2011

NGOs, IAOMT urge to ban mercury-containing products, including dental amalgam

Mercury, the main ingredient in "silver" or amalgam fillings, will be the subject of a United Nations conference to be held in Chiba, Japan on January 24-28. Members of various non-governmental organizations, as well as dentists and scientists from groups such as the International Academy of Oral Medicine and Toxicology, will be attending and urging a ban on products containing mercury, including dental amalgam.

21 Jan 2011

Fat linked with DNA chemical changes may help identify risk of cardiovascular disease, diabetes

Fat appears to associate with some distinctive chemical changes in the DNA - a finding that may help explain why obesity can increase the risk for chronic problems such as cardiovascular disease and diabetes, researchers report.

21 Jan 2011

Health Canada approves Labopharm's OLEPTRO for treatment of Major Depressive Disorder

Labopharm Inc. today announced that Health Canada's Therapeutic Products Directorate (TPD) has approved OLEPTRO, a novel once-daily formulation of the antidepressant trazodone, for the symptomatic relief of Major Depressive Disorder in adults.

21 Jan 2011

Researchers take systematic approach to catalog factors that control blood cell development

A small pool of stem cells replenishes the human body with about 200 billion new blood cells daily. But the elaborate circuitry that determines if a cell will develop into a T cell, red blood cell, or one of the nine or more other blood cell types remains largely unknown. A research team led by scientists from the Broad Institute and Brigham and Women's Hospital has taken a systematic approach to help decipher this circuitry, compiling a comprehensive catalog of the factors that determine a blood cell's fate.

21 Jan 2011

Repligen enters exclusive license agreement with UCI for use of HDAC3 inhibitors for memory disorders

Repligen Corporation announced today that it has entered into an exclusive license agreement with the University of California, Irvine (UCI) for a patent application covering the use of histone deacetylase 3 (HDAC3) inhibitors for the treatment of disorders involving preservation or extinction of memory including Alzheimer's disease, memory impairment and post traumatic stress disorder.

21 Jan 2011

Researchers believe driver mutations promote development, growth of prostate cancer

Prostate cancer is known to occur typically in older men. Yet some patients are younger than 50 years at the time of diagnosis. Scientists assume that these cases might be the key to understanding the biology of this disease. Early prostate cancer might be a subtype which is characterized by a relatively small number of genetic modifications.

21 Jan 2011

Employees with heart attack, ACS are major source of health costs

Employees with myocardial infarction and other types of acute coronary syndrome are a major source of direct and indirect health costs, reports a study in the January Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

21 Jan 2011

Porter Adventist Hospital offers tips for healthier eating habits

It's now been a few weeks since we have made our New Year's resolutions to eat better and finally lose those last five pounds or more. It's time to check in and see if you've set yourself up for success this year. Brittany Glassett, registered dietitian at Porter Adventist Hospital has a few tips to keep in mind when setting - and keeping - new goals.

21 Jan 2011

Positive results from nimotuzumab Phase II study for gastric cancer

YM BioSciences, a life sciences product development company advancing a diverse portfolio of promising hematology and cancer-related products at various stages of development, today announced that results were reported from a randomized Phase II gastric cancer study of nimotuzumab being conducted by its licensees, Daiichi Sankyo Co., Ltd. in Japan and Kuhnil Pharma Co. Ltd., in Korea.

21 Jan 2011

Three ASM scientists to receive NAS award for excellence in microbiology field

Three members of the American Society for Microbiology are among the 13 scientists that will be honored by the National Academy of Sciences with awards recognizing extraordinary scientific achievement in the field of microbiology:

21 Jan 2011

Medical Condition News

EDAP announces placement of first Sonolith i-sys electroconductive lithotripter in South Africa

Scientist receives RO1 research grant to improve blood, marrow transplantation in myeloma patients

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Study evaluates Masimo SpHb's accuracy in monitoring low hemoglobin levels

Researchers examine brain's role in breathing

MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium

Cell binding mechanism can lead to new treatments for skin diseases, lethal heart defects

EHSI's NASA bioreactor will help reduce pain and trauma caused by harvesting of adult stem cells

INF2 gene mutation is a major cause for focal segmental glomerulosclerosis

Routine mammograms can show arterial calcium deposits in women with ESRD, CKD

NGOs, IAOMT urge to ban mercury-containing products, including dental amalgam

Fat linked with DNA chemical changes may help identify risk of cardiovascular disease, diabetes

Health Canada approves Labopharm's OLEPTRO for treatment of Major Depressive Disorder

Researchers take systematic approach to catalog factors that control blood cell development

Repligen enters exclusive license agreement with UCI for use of HDAC3 inhibitors for memory disorders

Researchers believe driver mutations promote development, growth of prostate cancer

Employees with heart attack, ACS are major source of health costs

Porter Adventist Hospital offers tips for healthier eating habits

Positive results from nimotuzumab Phase II study for gastric cancer

Three ASM scientists to receive NAS award for excellence in microbiology field

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News